Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
55.4M
-
Number of holders
-
42
-
Total 13F shares, excl. options
-
42.4M
-
Shares change
-
+1.15M
-
Total reported value, excl. options
-
$479M
-
Value change
-
+$9.71M
-
Number of buys
-
21
-
Number of sells
-
-13
-
Price
-
$11.33
Significant Holders of Omega Therapeutics, Inc. - COMMON STOCK (OMGAQ) as of Q4 2021
48 filings reported holding OMGAQ - Omega Therapeutics, Inc. - COMMON STOCK as of Q4 2021.
Omega Therapeutics, Inc. - COMMON STOCK (OMGAQ) has 42 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 42.4M shares
of 55.4M outstanding shares and own 76.58% of the company stock.
Largest 10 shareholders include Flagship Pioneering Inc. (25.9M shares), FMR LLC (4.43M shares), HarbourVest Partners LLC (2.65M shares), Artal Group S.A. (2.27M shares), STATE OF WISCONSIN INVESTMENT BOARD (1.86M shares), CHI Advisors LLC (1.06M shares), BlackRock Inc. (1.03M shares), Monashee Investment Management LLC (441K shares), PLATINUM INVESTMENT MANAGEMENT LTD (415K shares), and SPHERA FUNDS MANAGEMENT LTD. (353K shares).
This table shows the top 42 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.